BSX · News · 20261104N
Revenue Performance and Mix
BOSTON SCIENTIFIC CORP · 2026-11-04 · Importance 45 · Surprise 50 · No source text
Boston Scientific reported third-quarter 2026 revenue of $5.14 billion, up 1.5% year over year on a reported, operational and organic basis. Organic sales growth was below the company’s prior 3%–5% guidance. An August cybersecurity incident caused an eight-business-day disruption to the global network and reduced organic sales growth by approximately 300 basis points, affecting manufacturing and shipments.
Key facts
- Third-quarter revenues rose 1.5% year over year to $5.14 billion on a reported, operational and organic basis. source
- Boston Scientific reported third-quarter 2026 organic sales growth of 1.5%, below its prior 3%-5% guidance. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | realized | +1.5% | Third-quarter revenues rose 1.5% year over year to $5.14 billion on a reported, operational and organic basis. |